Chewy’s Return On Capital Employed Overview

Benzinga Pro data, Chewy (NYSE:CHWY) reported Q3 sales of $2.21 billion. Earnings fell to a loss of $32.24 million, resulting in a 93.22% decrease from last quarter.

Benzinga Pro data, Chewy (NYSE:CHWY) reported Q3 sales of $2.21 billion. Earnings fell to a loss of $32.24 million, resulting in a 93.22% decrease from last quarter. In Q2, Chewy brought in $2.15 billion in sales but lost $16.69 million in earnings.

Why Is ROCE Significant?

Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, Chewy posted an ROCE of -0.49%.

It is important to keep in mind that ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company’s recent performance, but does not account for factors that could affect earnings and sales in the near future.

ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows Chewy is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.

For Chewy, a negative ROCE ratio of -0.49% suggests that management may not be effectively allocating their capital. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns; poor capital allocation can be a leech on the performance of a company over time.

Upcoming Earnings Estimate

Chewy reported Q3 earnings per share at $-0.08/share, which did not meet analyst predictions of $-0.04/share.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Earnings Preview: Kura Oncology

Kura Oncology (NASDAQ:KURA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that Kura Oncology will report an earnings per share (EPS) of $-0.52.

KURA

Read More

News Earnings Preview

News (NASDAQ:NWSA) is set to give its latest quarterly earnings report on Thursday, 2022-02-03. Here's what investors need to know before the announcement. Analysts estimate that News will likely report an Earnings Per Share (EPS) of $0.31.

NWSA

Read More

Recap: Conmed Q2 Earnings

Conmed (NYSE:CNMD) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Conmed beat estimated earnings by 1.33%, reporting an EPS of $0.76 versus an estimate of $0.75.

CNMD